Proteomics bags US patent for endometriosis test
Proteomics International Laboratories secured a US patent for its PromarkerEndo blood test for endometriosis, significantly enhancing its commercial prospects. The test, which addresses a common condition affecting one in nine women, aims to shorten the seven-year average diagnosis time. CEO David Morris hailed the patent as a major achievement that bolsters future partnerships and reimbursement efforts.
Take it further — get the full app and never miss a moment of what's happening in Australia.
This publisher's site can't be shown here due to their security settings.
Open full article →No source link available for this article.
Published 08 Jul 2026, 04:28 UTC · Updated 08 Jul 2026, 04:30 UTC
Summary by OZbrief Editorial. Original report: SMH. Editorial policy · Corrections
Trending
- Breaking: Senior WA minister Paul Papalia set to resign, triggering by-election
- Lachie Perrem suffers severe burns after robotic vacuum explodes at home
- Pioneer of ‘extreme male brain’ theory of autism now says phrase unhelpful
- Launceston entrepreneur's $80 million creative precinct plan falters amid insolvency links
- Workplace watchdog rules on Jess Wilson’s forklift-driving social media stunt
- Meet the comedian parodying Karl Stefanovic: ‘He’s cosplaying a conservative’